These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Yilmaz MI; Siriopol D; Saglam M; Kurt YG; Unal HU; Eyileten T; Gok M; Cetinkaya H; Oguz Y; Sari S; Vural A; Mititiuc I; Covic A; Kanbay M Kidney Int; 2014 Dec; 86(6):1213-20. PubMed ID: 24988065 [TBL] [Abstract][Full Text] [Related]
6. Endocan as a marker of microvascular inflammation in kidney transplant recipients. Lee YH; Kim SY; Moon H; Seo JW; Kim DJ; Park SH; Kim YG; Moon JY; Kim JS; Jeong KH; Lim SJ; Kim CD; Park JB; Chung BH; Kim YH; Yang J; Yang HI; Kim KS; Lee SH Sci Rep; 2019 Feb; 9(1):1854. PubMed ID: 30755622 [TBL] [Abstract][Full Text] [Related]
7. The Relationship between Vascular Biomarkers (Serum Endocan and Endothelin-1), NT-proBNP, and Renal Function in Chronic Kidney Disease, IgA Nephropathy: A Cross-Sectional Study. Sági B; Vas T; Gál C; Horváth-Szalai Z; Kőszegi T; Nagy J; Csiky B; Kovács TJ Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408883 [TBL] [Abstract][Full Text] [Related]
8. Endocan: A novel inflammatory indicator in cardiovascular disease? Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266 [TBL] [Abstract][Full Text] [Related]
10. Increased circulating endocan in patients with cirrhosis: relation to bacterial infection and severity of disease. Zuwala-Jagiello J; Simon K; Kukla M; Murawska-Cialowicz E; Gorka-Dynysiewicz J; Grzebyk E; Pazgan-Simon M J Physiol Pharmacol; 2017 Apr; 68(2):273-282. PubMed ID: 28614777 [TBL] [Abstract][Full Text] [Related]
11. Serum endocan levels as a marker of disease activity in patients with Behçet disease. Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522 [TBL] [Abstract][Full Text] [Related]
12. Could "calprotectin" and "endocan" serve as "Troponin of Nephrologists"? Azimi A Med Hypotheses; 2017 Feb; 99():29-34. PubMed ID: 28110693 [TBL] [Abstract][Full Text] [Related]
13. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism. Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872 [TBL] [Abstract][Full Text] [Related]
15. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504 [TBL] [Abstract][Full Text] [Related]
16. Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients. Oka S; Obata Y; Sato S; Torigoe K; Sawa M; Abe S; Muta K; Ota Y; Kitamura M; Kawasaki S; Hirose M; Uramatsu T; Mukae H; Nishino T Med Sci Monit; 2017 Mar; 23():1464-1470. PubMed ID: 28343234 [TBL] [Abstract][Full Text] [Related]
17. Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Kurtoglu E; Demir M; Celik T; Turker T; Iyisoy A Angiology; 2014 Oct; 65(9):773-7. PubMed ID: 24402320 [TBL] [Abstract][Full Text] [Related]
18. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients. Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453 [TBL] [Abstract][Full Text] [Related]